- Home
- DCTH vs DBI Comparison
DCTH vs DBI Comparison
Compare DCTH & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- DBI
- Stock Information
- Founded
- DCTH 1988
- DBI 1991
- Country
- DCTH United States
- DBI United States
- Employees
- DCTH N/A
- DBI N/A
- Industry
- DCTH Medical/Dental Instruments
- DBI Clothing/Shoe/Accessory Stores
- Sector
- DCTH Health Care
- DBI Consumer Discretionary
- Exchange
- DCTH Nasdaq
- DBI Nasdaq
- Market Cap
- DCTH 485.5M
- DBI 178.0M
- IPO Year
- DCTH N/A
- DBI 1991
- Fundamental
- Price
- DCTH $12.50
- DBI $3.04
- Analyst Decision
- DCTH Strong Buy
- DBI Hold
- Analyst Count
- DCTH 4
- DBI 2
- Target Price
- DCTH $24.00
- DBI $3.50
- AVG Volume (30 Days)
- DCTH 785.8K
- DBI 2.5M
- Earning Date
- DCTH 08-04-2025
- DBI 06-10-2025
- Dividend Yield
- DCTH N/A
- DBI 6.58%
- EPS Growth
- DCTH N/A
- DBI N/A
- EPS
- DCTH N/A
- DBI N/A
- Revenue
- DCTH $53,850,000.00
- DBI $2,949,575,000.00
- Revenue This Year
- DCTH $155.42
- DBI N/A
- Revenue Next Year
- DCTH $37.93
- DBI $2.45
- P/E Ratio
- DCTH N/A
- DBI N/A
- Revenue Growth
- DCTH 1068.87
- DBI N/A
- 52 Week Low
- DCTH $7.17
- DBI $2.18
- 52 Week High
- DCTH $18.23
- DBI $8.45
- Technical
- Relative Strength Index (RSI)
- DCTH 33.81
- DBI 56.93
- Support Level
- DCTH $13.30
- DBI $2.37
- Resistance Level
- DCTH $14.15
- DBI $2.36
- Average True Range (ATR)
- DCTH 0.64
- DBI 0.19
- MACD
- DCTH -0.26
- DBI 0.08
- Stochastic Oscillator
- DCTH 8.28
- DBI 91.58
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.